{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T04:13:58Z","timestamp":1743048838692,"version":"3.40.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"DOI":"10.7759\/cureus.81225","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T12:56:42Z","timestamp":1742993802000},"source":"Crossref","is-referenced-by-count":0,"title":["Glycemic Control Status After Six Months in Post-COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Chowdhury Adnan","family":"Sami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ferdous Ur","family":"Rahaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Mizanur Rahman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Monzurul","family":"Alam Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Abdul","family":"Matin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan M","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed H","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohael Mahmud","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Nazmul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11417","article-title":"Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review","volume":"4","author":"Nasserie T","year":"2021","unstructured":"Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021, 4:e2111417. 10.1001\/jamanetworkopen.2021.11417","journal-title":"JAMA Netw Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2023.104779","article-title":"Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - lessons to learn in long COVID?","volume":"53","author":"L\u00f8kke FB","year":"2023","unstructured":"L\u00f8kke FB, Hansen KS, Dalgaard LS, \u00d6brink-Hansen K, Schi\u00f8ttz-Christensen B, Leth S. Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - lessons to learn in long COVID?. Infect Dis Now. 2023, 53:104779. 10.1016\/j.idnow.2023.104779","journal-title":"Infect Dis Now"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108166","article-title":"Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus","volume":"164","author":"Chee YJ","year":"2020","unstructured":"Chee YJ, Ng SJ, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020, 164:108166. 10.1016\/j.diabres.2020.108166","journal-title":"Diabetes Res Clin Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang JK","year":"2010","unstructured":"Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010, 47:193-9. 10.1007\/s00592-009-0109-4","journal-title":"Acta Diabetol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen Y","year":"2020","unstructured":"Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020, 525:135-40. 10.1016\/j.bbrc.2020.02.071","journal-title":"Biochem Biophys Res Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa108","article-title":"Endocrine significance of SARS-CoV-2's reliance on ACE2","volume":"161","author":"Lazartigues E","year":"2020","unstructured":"Lazartigues E, Qadir MM, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2's reliance on ACE2. Endocrinology. 2020, 161:bqaa108. 10.1210\/endocr\/bqaa108","journal-title":"Endocrinology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection","volume":"18","author":"Liu F","year":"2020","unstructured":"Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. 2020, 18:2128-30.e2. 10.1016\/j.cgh.2020.04.040","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101998","article-title":"Decoding the immune dance: unraveling the interplay between beta cells and type 1 diabetes","volume":"88","author":"Roy S","year":"2024","unstructured":"Roy S, Pokharel P, Piganelli JD. Decoding the immune dance: unraveling the interplay between beta cells and type 1 diabetes. Mol Metab. 2024, 88:101998. 10.1016\/j.molmet.2024.101998","journal-title":"Mol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano T","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021, 33:127-48. 10.1093\/intimm\/dxaa078","journal-title":"Int Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco L","year":"2021","unstructured":"Montefusco L, Ben Nasr M, D'Addio F, et al.. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021, 3:774-85. 10.1038\/s42255-021-00407-6","journal-title":"Nat Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.74645.1","article-title":"Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients","volume":"11","author":"Pijls BG","year":"2022","unstructured":"Pijls BG, Jolani S, Atherley A, et al.. Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients. F1000Res. 2022, 11:5. 10.12688\/f1000research.74645.1","journal-title":"F1000Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101320-125133","article-title":"Sex differences in immunity","volume":"40","author":"Wilkinson NM","year":"2022","unstructured":"Wilkinson NM, Chen HC, Lechner MG, Su MA. Sex differences in immunity. Annu Rev Immunol. 2022, 40:75-94. 10.1146\/annurev-immunol-101320-125133","journal-title":"Annu Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi T","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P, et al.. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020, 588:315-20. 10.1038\/s41586-020-2700-3","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082948","article-title":"Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D","volume":"21","author":"La Vignera S","year":"2020","unstructured":"La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE. Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Int J Mol Sci. 2020, 21:2948. 10.3390\/ijms21082948","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02536-6","article-title":"Sex differences in COVID-19: the role of androgens in disease severity and progression","volume":"71","author":"Mohamed MS","year":"2021","unstructured":"Mohamed MS, Moulin TC, Schi\u00f6th HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021, 71:3-8. 10.1007\/s12020-020-02536-6","journal-title":"Endocrine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham H","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C, et al.. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020, 11:6317. 10.1038\/s41467-020-19741-6","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in Covid-19","volume":"383","author":"Rubino F","year":"2020","unstructured":"Rubino F, Amiel SA, Zimmet P, et al.. New-onset diabetes in Covid-19. N Engl J Med. 2020, 383:789-90. 10.1056\/NEJMc2018688","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14269","article-title":"Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis","volume":"23","author":"Sathish T","year":"2021","unstructured":"Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021, 23:870-4. 10.1111\/dom.14269","journal-title":"Diabetes Obes Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113094","article-title":"The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan","volume":"11","author":"Zhang J","year":"2022","unstructured":"Zhang J, Shu T, Zhu R, Yang F, Zhang B, Lai X. The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan. J Clin Med. 2022, 11:3094. 10.3390\/jcm11113094","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years - United States, March 1, 2020-June 28, 2021","volume":"71","author":"Barrett CE","year":"2022","unstructured":"Barrett CE, Koyama AK, Alvarez P, et al.. Risk for newly diagnosed diabetes &gt;30 days after SARS-CoV-2 infection among persons aged &lt;18 years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022, 71:59-65. 10.15585\/mmwr.mm7102e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05670-0","article-title":"Incidence of newly diagnosed diabetes after Covid-19","volume":"65","author":"Rathmann W","year":"2022","unstructured":"Rathmann W, Kuss O, Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022, 65:949-54. 10.1007\/s00125-022-05670-0","journal-title":"Diabetologia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang L","year":"2020","unstructured":"Yang L, Han Y, Nilsson-Payant BE, et al.. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020, 27:125-36.e7. 10.1016\/j.stem.2020.06.015","journal-title":"Cell Stem Cell"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.10.002","article-title":"Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes","volume":"47","author":"Sathish T","year":"2021","unstructured":"Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2021, 47:101204. 10.1016\/j.diabet.2020.10.002","journal-title":"Diabetes Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100745","article-title":"Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system","volume":"46","author":"Lazzaroni MG","year":"2021","unstructured":"Lazzaroni MG, Piantoni S, Masneri S, et al.. Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021, 46:100745. 10.1016\/j.blre.2020.100745","journal-title":"Blood Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.649525","article-title":"COVID-19 and diabetes: understanding the interrelationship and risks for a severe course","volume":"12","author":"Landstra CP","year":"2021","unstructured":"Landstra CP, de Koning EJ. COVID-19 and diabetes: understanding the interrelationship and risks for a severe course. Front Endocrinol (Lausanne). 2021, 12:649525. 10.3389\/fendo.2021.649525","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14288","article-title":"COVID-19 and diabetes: insulin requirements parallel illness severity in critically unwell patients","volume":"93","author":"Wu L","year":"2020","unstructured":"Wu L, Girgis CM, Cheung NW. COVID-19 and diabetes: insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol (Oxf). 2020, 93:390-3. 10.1111\/cen.14288","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110151","article-title":"Dexamethasone-induced hyperglycaemia in COVID-19: glycaemic profile in patients without diabetes and factors associated with hyperglycaemia","volume":"194","author":"Rhou YJ","year":"2022","unstructured":"Rhou YJ, Hor A, Wang M, Wu YF, Jose S, Chipps DR, Cheung NW. Dexamethasone-induced hyperglycaemia in COVID-19: glycaemic profile in patients without diabetes and factors associated with hyperglycaemia. Diabetes Res Clin Pract. 2022, 194:110151. 10.1016\/j.diabres.2022.110151","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351579-glycemic-control-status-after-six-months-in-post-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T12:56:44Z","timestamp":1742993804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351579-glycemic-control-status-after-six-months-in-post-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.81225","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}